Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026)

Alphatec Holdings (ATEC) reported Cash from Financing Activities of -$1.8 million for Q1 2026, down 105.77% on a YoY basis from $30.8 million in Q1 2025, and down 961.17% sequentially from $206000.0 in Q4 2025.

Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Alphatec Holdings (ATEC) has 17 years of Cash from Financing Activities data on file, last reported at -$1.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 105.77% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (down 102.75% YoY), and the FY2025 full-year result was $30.0 million, down 46.59% from the prior year.
  • Cash from Financing Activities slipped to -$1.8 million in Q1 2026, from $206000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $151.6 million in Q4 2023 to a low of -$4.4 million in Q1 2024.
  • A 5-year average of $27.8 million and a median of $3.2 million in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities soared 14862.59% in 2023 and sank 119.61% in 2025, its largest moves.
  • Tracing ATEC's Cash from Financing Activities over 5 years: stood at $1.0 million in 2022, then soared by 14862.59% to $151.6 million in 2023, then slumped by 66.59% to $50.6 million in 2024, then plunged by 99.59% to $206000.0 in 2025, then tumbled by 961.17% to -$1.8 million in 2026.
  • Business Quant data shows ATEC's Cash from Financing Activities at -$1.8 million in Q1 2026, $206000.0 in Q4 2025, and -$1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Alphatec Holdings 1.26 Bn 1.12 Bn 136.48 Mn -1.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.77 Mn
Mar 31, 2026 -1.77 Mn
Dec 31, 2025 206,000.00
Dec 31, 2025 206,000.00
Sep 30, 2025 -1.31 Mn
Sep 30, 2025 -1.31 Mn
Jun 30, 2025 366,000.00
Jun 30, 2025 366,000.00
Mar 31, 2025 30.76 Mn
Mar 31, 2025 30.76 Mn
Dec 31, 2024 50.64 Mn
Dec 31, 2024 50.64 Mn
Sep 30, 2024 6.69 Mn
Sep 30, 2024 6.69 Mn
Jun 30, 2024 3.24 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 -4.37 Mn
Mar 31, 2024 -4.37 Mn
Dec 31, 2023 151.57 Mn
Dec 31, 2023 151.57 Mn